LUNG DISEASES, INTERSTITIAL
Clinical trials for LUNG DISEASES, INTERSTITIAL explained in plain language.
Never miss a new study
Get alerted when new LUNG DISEASES, INTERSTITIAL trials appear
Sign up with your email to follow new studies for LUNG DISEASES, INTERSTITIAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Researchers track Real-World side effects of ofev in lung disease patients
Knowledge-focused OngoingThis study monitors the long-term safety of the drug Ofev in patients with systemic scleroderma-associated interstitial lung disease (SSc-ILD) in Japan. Researchers are tracking side effects, especially stomach issues like diarrhea and nausea, that occur in everyday use. About 58…
Matched conditions: LUNG DISEASES, INTERSTITIAL
Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated May 17, 2026 05:09 UTC
-
New study tracks lung function and symptoms in rare lung disease patients on nintedanib
Knowledge-focused OngoingThis study looks at 88 adults with connective tissue disease-related progressive lung scarring who are taking the drug nintedanib. Researchers want to see if changes in lung function over 24 months are linked to changes in cough and shortness of breath. The goal is to better unde…
Matched conditions: LUNG DISEASES, INTERSTITIAL
Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC
-
Firefighters get new screening for hidden lung risks
Knowledge-focused TerminatedThis study aimed to give firefighters low-dose chest CT scans to check for lung cancer and other lung diseases caused by smoke and chemical exposure. It focused on firefighters aged 35 and older who never smoked or quit long ago. The study was withdrawn before enrolling anyone, s…
Matched conditions: LUNG DISEASES, INTERSTITIAL
Phase: NA • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC